Tan Jianjun


Personal profile

Name: Tan Jianjun

GenderMale

DegreesPh.D

Title: Professor

E-mail: tanjianjun@bjut.edu.cn

Current Professional Societies

1.Editorial board members for Current Chinese Science, 2021-

2.Editorial board members for medicinal chemistry, 2018-

3.Editorial board members for Symbiosis Journal of Virology & Retrovirology, 2013-

4.Editorial board members for Hans Journal of Computational Biology, 2013

Research Areas

Computational biology; interaction protein-protein, protein-ligand

Publications

[1]Men, J. R.; Tan, J. J*.; Sun, H. L. The Identification and Analysis of a miRNA Risk Score Model for Hepatocellular Carcinoma Prognosis. Prog. Biochem. Biophys. 2020, 47(4), 344-360.

[2]Cheng, S. P.; Zhang, L.; Tan, J. J*.; Gong, W. K.; Li, C. H.; Zhang, X. Y. DM-RPIs: Predicting ncRNA-protein interactions using stacked ensembling strategy.Comput. Biol. Chem. 2019, 83.

[3]Zhang, L.; Tan, J*.; Han, D.; Zhu, H. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.Drug Discov. Today 2017, 22(11), 1680-1685.

[4]Tan, J*.; Yuan, H.; Li, C.; Zhang, X.; Wang, C. Insights into the Functions of M-T Hook Structure in HIV Fusion Inhibitor Using Molecular Modeling.Comput. Biol. Chem. 2016, 61, 202-9.

[5]Tan, J*.; Su, M.; Zeng, Y.; Wang, C. Design, synthesis and activity evaluation of novel peptide fusion inhibitors targeting HIV-1 gp41.Bioorg. Med. Chem. 2016, 24(2), 201-206.

[6]Han, D.; Su, M.; Tan, J. J*.; Li, C. H.; Zhang, X. Y.; Wang, C. X. Structure-activity relationship and binding mode studies for a series of diketo-acids as HIV integrase inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulations.Rsc Adv 2016, 6(33), 27594-27606.

Personal Statement

Tan Jianjun, the professor and Ph.D. supervisor, has completed more than 17 research projects, including those funded by the National Key Basic Research Program of China and National Natural Science Foundation of China, 2 of which are ongoing. He accumulated abundant experience in molecular design and drug design. Also, he published more than 100 papers on core journals at home and abroad, more than 50 of which were listed in the journal indexed by SCI.